EUVIMEDEUVIMED entdecken
Crossref

Anti‐ HNA testing of allo‐exposed COVID ‐19 convalescent plasma donors including genetic human neutrophil antigen screening to prevent anti‐ HNA antibody‐mediated transfusion‐related acute lung injury

Katarzyna Guz iD, Patrycja Łopacz, Małgorzata Uhrynowska, Karolina Piaskowska, Beata Szczepaniak, Magdalena Krzemienowska, Sylwia Purchla-Szepioła, Anna Główka, Eliza Głodkowska-Mrówka, Agnieszka Orzińska iD

Transfusion · 2024

DOI: 10.1111/trf.17962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transfusion, 2024. Verfasst von Katarzyna Guz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematological and Transfusion Immunology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland. Hauptthemen laut MEDLINE: COVID-19, Transfusion-Related Acute Lung Injury, Blood Donors, Immunization, Passive. Die Arbeit nennt 31 Literaturangaben. Gefördert von: Institute of Hematology and Transfusion Medicine funds and the subsidy for the public blood transfusion service of the Polish Ministry of Health and the Nation….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Transfusion‐related acute lung injury caused by antibodies against human neutrophil antigens (HNA) is a serious but rare complication associated with blood transfusion. The presence of such antibodies is most probable in donors with a transfusion/pregnancy history. During the COVID‐19 pandemic period convalescent plasma (CP) containing neutralizing antibodies against SARS‐CoV‐2 was widely used for COVID‐19 patients as a therapy in the absence of any treatment. The aim of the study was to work out a simple diagnostic algorithm of anti‐HNA testing of allo‐exposed CP donors including genetic HNA screening. Materials and Methods A total of 457 anti‐HLA‐negative allo‐exposed CP donors were genotyped for HNA‐1a/1b, HNA‐3a/3b, and HNA‐2, and only donors with homozygous HNA‐1a/1a; HNA‐3b/3b; or HNA‐2null genotypes were tested for anti‐HNA antibody using LabScreenMulti (One Lambda) and homozygous HNA‐1b/1b using the granulocyte immunofluorescence test (GIFT) but verified using LabScreenMulti.

Results

Testing of 83 homozygous HNA‐3b/3b; HNA‐2null; or HNA‐1a/1a donors revealed anti‐HNA‐3a antibody in one case. Testing of 181 HNA‐1b/1b donors using GIFT gave 10 ambiguous results verified using LabScreenMulti which confirmed anti‐HNA‐1a antibody in one case. The frequency of FCGR3B*01 and *04 encoding HNA‐1a was 0.34; FCGR3B*02 , *03 , and *05 encoding HNA‐1b—0.66; SLC44A2*01 encoding HNA‐3a—0.80; and SLC44A2*02 encoding HNA‐3b—0.20. In 3.7% cases the HNA‐2null genotype was revealed.

Discussion

Due to applying HNA genotyping as a primary test before anti‐HNA antibody testing the serological work was limited only to HNA‐homozygous donors revealing two anti‐HNA immunized donors. The distribution of HNA genotypes in the cohort was similar to other Caucasian populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Transfusion-Related Acute Lung InjuryBlood DonorsImmunization, PassiveSARS-CoV-2COVID-19 SerotherapyNeutrophilsHumansFemaleMaleAdultIsoantigensMiddle AgedIsoantibodiesDonor SelectionGenotypeAcute Lung Injury

Stichwörter der Autor:innen

COVID‐19 convalescent plasma donorsHNATRALIanti‐HNA antibodyhuman neutrophil antigenstransfusion‐related acute lung injury

Substanzen

IsoantigensIsoantibodies

Autor:innen und Institutionen

  • Department of Hematological and Transfusion Immunology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.

ORCID-Profile: Katarzyna Guz, Agnieszka Orzińska

Förderung

  • Institute of Hematology and Transfusion Medicine funds and the subsidy for the public blood transfusion service of the Polish Ministry of Health and the Nation…

Zitieren

APA

Guz, K., Łopacz, P., Uhrynowska, M., Piaskowska, K., Szczepaniak, B., Krzemienowska, M., Purchla-Szepioła, S., Główka, A., Głodkowska-Mrówka, E., & Orzińska, A. (2024). Anti‐ HNA testing of allo‐exposed COVID ‐19 convalescent plasma donors including genetic human neutrophil antigen screening to prevent anti‐ HNA antibody‐mediated transfusion‐related acute lung injury. Transfusion. https://doi.org/10.1111/trf.17962

Vancouver

Guz K, Łopacz P, Uhrynowska M, Piaskowska K, Szczepaniak B, Krzemienowska M, et al. Anti‐ HNA testing of allo‐exposed COVID ‐19 convalescent plasma donors including genetic human neutrophil antigen screening to prevent anti‐ HNA antibody‐mediated transfusion‐related acute lung injury. Transfusion. 2024. doi:10.1111/trf.17962

BibTeX
@article{Guz2024,
  author = {Guz, Katarzyna and Łopacz, Patrycja and Uhrynowska, Małgorzata and Piaskowska, Karolina and Szczepaniak, Beata and Krzemienowska, Magdalena and Purchla-Szepioła, Sylwia and Główka, Anna and Głodkowska-Mrówka, Eliza and Orzińska, Agnieszka},
  title = {Anti‐ HNA testing of allo‐exposed COVID ‐19 convalescent plasma donors including genetic human neutrophil antigen screening to prevent anti‐ HNA antibody‐mediated transfusion‐related acute lung injury},
  journal = {Transfusion},
  year = {2024},
  doi = {10.1111/trf.17962}
}
Kostenlos starten →